PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolism

Authors

Simon H. Bridge, Newcastle University
David A. Sheridan, Peninsula Medical School
Daniel J. Felmlee, Peninsula Medical School
Mary M.E. Crossey, Imperial College Healthcare NHS Trust
Fiona I. Fenwick, Newcastle University
Clare V. Lanyon, Northumbria University
Geneviève Dubuc, University of Montreal
Nabil G. Seidah, University of Montreal
Jean Davignon, University of Montreal
Howard C. Thomas, Imperial College Healthcare NHS Trust
Simon D. Taylor-Robinson, Imperial College Healthcare NHS Trust
Geoffrey L. Toms, Newcastle University
R. Dermot G. Neely, Newcastle University
Margaret F. Bassendine, Newcastle University

ORCID

• David A. Sheridan: 0000-0001-5100-814X
• Daniel J. Felmlee: 0000-0001-8350-122X

DOI Link

10.1016/j.jhep.2014.11.016

DOI

10.1016/j.jhep.2014.11.016

Publication Date

2015-01-01

Publication Title

Journal of Hepatology

Volume

62

Issue

4

ISSN

0168-8278

First Page

763

Last Page

770

Recommended Citation

Bridge, S., Sheridan, D., Felmlee, D., Crossey, M., Fenwick, F., Lanyon, C., Dubuc, G., Seidah, N., Davignon, J., Thomas, H., Taylor-Robinson, S., Toms, G., Neely, R., & Bassendine, M. (2015) 'PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolism', Journal of Hepatology, 62(4), pp. 763-770. Available at: 10.1016/j.jhep.2014.11.016